Clinical Trials

42 enrolled

Gastric Cancer Peritoneal Metastases

NCT05832892 2024-06-14

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

Phase 1/2 Unknown

41 enrolled

Pancreatic Neoplasms

NCT04151277 2024-02-08

PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

500 enrolled

Pancreatic Neoplasms

NCT05828381 2023-04-25

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

33 enrolled

Esophageal Neoplasms

NCT05669807 2023-01-03

Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

184 enrolled

Second Line Treatment of Gastric Cancer

NCT05653817 2022-12-16

Advanced or Metastatic Cholangiocarcinoma

Phase NA Unknown

60 enrolled

Cholangiocarcinoma

NCT05640791 2022-12-07

Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer

Resectable Biliary Tract Cancer

NCT05552651 2022-09-23

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT03487016 2022-09-08

FOOTPATH

270 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04460066 2022-05-04

A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.

Phase 1/2 Unknown

70 enrolled

Esophageal Neoplasms

NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Phase NA Unknown

46 enrolled

Advanced Gastric Adenocarcinoma

NCT03801668 2022-01-04

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

294 enrolled

Stomach Neoplasms

NCT05007145 2021-12-21

REVO

92 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04089150 2021-10-22

MASTERPLAN

120 enrolled

Pancreatic Neoplasms

NCT04835064 2021-04-08

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

600 enrolled

Pancreatic Adenocarcinoma

NCT03703063 2021-01-27

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT04602013 2020-10-26

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

53 enrolled

Esophageal Squamous Cell Carcinoma

NCT04581876 2020-10-09

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

120 enrolled

Pancreatic Neoplasms

NCT04216758 2020-06-30

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

300 enrolled

Stage IA Pancreatic Adenocarcinoma

NCT04443036 2020-06-23

Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma

Phase NA Unknown

44 enrolled

Stomach Neoplasms

NCT04135781 2020-03-23

Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

616 enrolled

Stomach Neoplasms

NCT04177875 2019-11-26

T+TP

44 enrolled

Esophageal Neoplasms

NCT02486601 2019-02-27

FOXAGAST

55 enrolled

Stomach Neoplasms

NCT03825328 2019-01-31

A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )

30 enrolled

Pancreatic Neoplasms

NCT03636308 2018-08-17

ASAGPAC

Pancreatic Neoplasms

NCT02975141 2018-08-13

AFFECT

12 enrolled

Pancreatic Neoplasms

NCT03435289 2018-02-19

A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

24 enrolled

Pancreatic Neoplasms

NCT01971281 2017-09-13

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Phase 1/2 Unknown

Pancreatic Neoplasms

NCT01964534 2017-01-31

AFUGEM

114 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02124317 2016-12-22

NAPSPAC

60 enrolled

Advanced Pancreatic Cancer

NCT02506842 2016-08-11

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

300 enrolled

Pancreatic Neoplasms

NCT01934634 2015-11-10

Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer

24 enrolled

Pancreatic Neoplasms

NCT02229045 2014-08-29

Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer

37 enrolled

Gastric Caner

NCT02135822 2014-05-16

NAPGAP

30 enrolled

Advanced Pancreatic Cancer

NCT01641783 2012-07-17

Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients